EP1850135 - Method for determining the thrombocyte function and flow conditions [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.09.2011 Database last updated on 22.08.2024 | Most recent event Tooltip | 04.10.2013 | Lapse of the patent in a contracting state New state(s): HU | published on 06.11.2013 [2013/45] | Applicant(s) | For all designated states Siemens Healthcare Diagnostics Products GmbH Görzhäuser Hof Emil-von-Behring-Strasse 76 35041 Marburg / DE | [2008/42] |
Former [2007/44] | For all designated states Dade Behring Marburg GmbH Emil-von-Behring-Strasse 76 35041 Marburg / DE | Inventor(s) | 01 /
Rechner, Andreas, Dr. Burgweg 5 35043 Marburg / DE | [2007/44] | Application number, filing date | 07007504.9 | 12.04.2007 | [2007/44] | Priority number, date | DE20061020386 | 28.04.2006 Original published format: DE102006020386 | [2007/44] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | EP1850135 | Date: | 31.10.2007 | Language: | DE | [2007/44] | Type: | B1 Patent specification | No.: | EP1850135 | Date: | 03.11.2010 | Language: | DE | [2010/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.07.2007 | Classification | IPC: | G01N33/86 | [2007/44] | CPC: |
G01N33/86 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2007/44] | Title | German: | Verfahren zur Bestimmung der Thrombozytenfunktion und der Flussbedingungen | [2007/44] | English: | Method for determining the thrombocyte function and flow conditions | [2007/44] | French: | Procédé de détermination de la fonction des thrombocytes et des conditions liquides | [2007/44] | Examination procedure | 02.05.2008 | Examination requested [2008/24] | 03.06.2008 | Despatch of a communication from the examining division (Time limit: M04) | 03.09.2008 | Reply to a communication from the examining division | 20.05.2010 | Communication of intention to grant the patent | 29.06.2010 | Fee for grant paid | 29.06.2010 | Fee for publishing/printing paid | Opposition(s) | 04.08.2011 | No opposition filed within time limit [2011/41] | Fees paid | Renewal fee | 28.04.2009 | Renewal fee patent year 03 | 19.04.2010 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 03.11.2010 | CZ | 03.11.2010 | DK | 03.11.2010 | EE | 03.11.2010 | FI | 03.11.2010 | HU | 03.11.2010 | LT | 03.11.2010 | LV | 03.11.2010 | MT | 03.11.2010 | PL | 03.11.2010 | RO | 03.11.2010 | SE | 03.11.2010 | SI | 03.11.2010 | SK | 03.11.2010 | TR | 03.11.2010 | BG | 03.02.2011 | GR | 04.02.2011 | IS | 03.03.2011 | PT | 03.03.2011 | LU | 12.04.2011 | BE | 30.04.2011 | MC | 30.04.2011 | [2013/45] |
Former [2013/44] | CY | 03.11.2010 | |
CZ | 03.11.2010 | ||
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
MT | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
TR | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
LU | 12.04.2011 | ||
BE | 30.04.2011 | ||
MC | 30.04.2011 | ||
Former [2013/26] | CY | 03.11.2010 | |
CZ | 03.11.2010 | ||
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
MT | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
LU | 12.04.2011 | ||
BE | 30.04.2011 | ||
MC | 30.04.2011 | ||
Former [2013/25] | CZ | 03.11.2010 | |
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
MT | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
LU | 12.04.2011 | ||
BE | 30.04.2011 | ||
MC | 30.04.2011 | ||
Former [2012/09] | CZ | 03.11.2010 | |
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
MT | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
BE | 30.04.2011 | ||
MC | 30.04.2011 | ||
Former [2012/05] | CZ | 03.11.2010 | |
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
MT | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
MC | 30.04.2011 | ||
Former [2012/01] | CZ | 03.11.2010 | |
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
MC | 30.04.2011 | ||
Former [2011/38] | CZ | 03.11.2010 | |
DK | 03.11.2010 | ||
EE | 03.11.2010 | ||
FI | 03.11.2010 | ||
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
PL | 03.11.2010 | ||
RO | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
SK | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
Former [2011/30] | FI | 03.11.2010 | |
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
SE | 03.11.2010 | ||
SI | 03.11.2010 | ||
BG | 03.02.2011 | ||
GR | 04.02.2011 | ||
IS | 03.03.2011 | ||
PT | 03.03.2011 | ||
Former [2011/23] | FI | 03.11.2010 | |
LT | 03.11.2010 | ||
LV | 03.11.2010 | ||
IS | 03.03.2011 | ||
Former [2011/19] | LT | 03.11.2010 | Documents cited: | Search | [DX]EP0716744 (DADE INT INC [US]) [DX] 1-8 * abstract * * claims 1,10,11,14 *; | [Y]WO02074322 (LEUVEN K U RES & DEV [BE], et al) [Y] 4,5 * claims 9,12 *; | [Y]WO2005007868 (ACCUMETRICS INC [US], et al) [Y] 9,10 * abstract * * figure 3; example 1; claim 1 * * page 1, paragraph 1 * * page 6, paragraph 1 * * page 15, paragraphs 3,4 *; | [X] - MISCHKE R ET AL, "Influence of platelet count, acetylsalicylic acid, von Willebrand's Disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs", VETERINARY JOURNAL, BAILLIERE TINDALL, LONDON,, GB, (200301), vol. 165, no. 1, ISSN 1090-0233, pages 43 - 52, XP002437870 [X] 1-8 * page 44, column 1, paragraph 4 * * abstract * DOI: http://dx.doi.org/10.1016/S1090-0233(02)00169-7 | [YX] - BIN XU ET AL, "Acyclic Analogues of Adenosine Biphosphates as P2Y Receptor Antagonists: Phosphate Substitution Leads to Multiple Pathways of Inhibition of Platelet Aggregation", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (2002), vol. 45, ISSN 0022-2623, pages 5694 - 5709, XP002285317 [Y] 9,10,12 * abstract * * page 5708, column 2, paragraph 3 * [X] 11 DOI: http://dx.doi.org/10.1021/jm020173u | [Y] - "PROD. NO. M5942 - MRS2395 CELL SIGNALING AND NEUROSCIENCE FIRST P2Y12 RECEPTOR ANTAGONIST AVAILABLE FROM SIGMA-RBI", SIGMA ALDRICH CATALOG, XX, XX, (2002), page 1, XP002437879 [Y] 10,12 * abstract * | [Y] - JUDGE H M ET AL, "Incomplete P2Y12 receptor blockade by Clopidogrel is not due to the presence of an internal pool of P2Y12 Receptors", JOURNAL OF THROMBOSIS AND HAEMOSTASIS, BLACKWELL PUBLISHING, OXFORD, GB, (200508), vol. 3, no. Supplement1, ISSN 1538-7933, page P2148, XP002437871 [Y] 10,12 * abstract * | [Y] - WIVIOTT STEPHEN D ET AL, "Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial", CIRCULATION, LIPPINCOT WILLIAMS AND WILKINS, BALTIMORE, US, (20050628), vol. 111, no. 25, ISSN 1524-4539, pages 3366 - 3373, XP002437872 [Y] 10 * abstract * DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA.104.502815 | [Y] - KAM P C A ET AL, "The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments", ANAESTHESIA, ACADEMIC PRESS, LONDON, GB, (200301), vol. 58, no. 1, ISSN 0003-2409, pages 28 - 35, XP002437873 [Y] 10 * abstract * DOI: http://dx.doi.org/10.1046/j.1365-2044.2003.02960.x | [Y] - KOZEK-LANGENECKER S A ET AL, "[Locoregional anesthesia and coagulation inhibitors. Recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine] LOKOREGIONALAESTHESIEN UNTER GERINNUNGSHEMMENDER MEDIKATION. EMPFEHLUNGEN DER ARBEITSGRUPPE PERIOPERATIVE GERINN", ANAESTHESIST, SPRINGER VERLAG, DE, (200505), vol. 54, no. 5, ISSN 0003-2417, pages 476 - 484, XP002437874 [Y] 4,5,8,10 * table 2 * DOI: http://dx.doi.org/10.1007/s00101-005-0827-0 | [Y] - ANDRE PATRICK ET AL, "Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis", CIRCULATION, LIPPINCOT WILLIAMS AND WILKINS, BALTIMORE, US, (20031125), vol. 108, no. 21, ISSN 1524-4539, pages 2697 - 2703, XP002437875 [Y] 8,10 * abstract * DOI: http://dx.doi.org/10.1161/01.CIR.0000093279.36628.12 | [Y] - HOUSTON DAYLE ET AL, "[P-32]2-iodo-N-6-methyl-(N)-methanocarba-2 '-deoxyadenosine-3 ',5 '-bisphosphate ([P-32]MRS2500), a novel radioligand for quantification of native P2Y(1) receptors", BRITISH JOURNAL OF PHARMACOLOGY, BASINGSTOKE, HANTS, GB, (200603), vol. 147, no. 5, ISSN 0007-1188, pages 459 - 467, XP002437876 [Y] 12 * abstract * DOI: http://dx.doi.org/10.1038/sj.bjp.0706453 | [Y] - JIN JIANGUO ET AL, "Adenosine diphosphate (ADP)-induced thromboxane A2 generation in human platelets requires coordinated signaling through integrin alphaIIbbeta3 and ADP receptors", BLOOD, W.B.SAUNDERS COMPANY, ORLANDO, FL, US, (20020101), vol. 99, no. 1, ISSN 0006-4971, pages 193 - 198, XP002437877 [Y] 10,12 * abstract * * page 193, column 2, paragraph 1 * DOI: http://dx.doi.org/10.1182/blood.V99.1.193 | [X] - MIYAMOTO K ET AL, "Stimulatory and inhibitory effects of forskolin on adenylate cyclase in rat normal hepatocytes and hepatoma cells.", JOURNAL OF PHARMACOBIO-DYNAMICS FEB 1989, (198902), vol. 12, no. 2, ISSN 0386-846X, pages 87 - 93, XP002441664 [X] 5-7 * abstract * |